[mepr-show rules=”18700″ unauth=”message”] Overview: Founded in 2013, Wells Bio, Inc. is a Korean firm which develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular technology. Test Name: CareUS™ COVID-19 IgM/IgG Testing Type: Qualitative rapid diagnostic antibody test Technology: The careUS™ COVID-19 IgM/IgG is an in vitro…
Browsing: Diagnostics
This section provides information on recently published research.
This COVID drama could soon end if we were to get smart on testing. Harvard professor Michael Mina is someone to watch. You will likely be seeing a lot of him in the coming weeks as he seems to have sorted out this COVID testing issue which we to date…
Information on the 7 companies selected thus from the NIH Shark tank competition which is offering $250 million in funding for companies that have prospects of developing rapid tests by the Autumn of 2020. After scrutinizing several dozen submissions the National Institutes of Health has selected its first seven projects…
The work to develop a rapid COVID-19 test is one of the most important challenges we face in the world today. Over 160 companies worldwide are in pursuit. Society is under extreme pressure from this pandemic. Accurate testing is the cornerstone of a return to some level of normalcy and…
Researchers are working on a testing system that would require a simple exhaled breath. Such a test would serve as an alternative to current tests that are expensive, can take a long time to get results, and require specialized personnel to do the sampling and to analyze the results. According…
A Covid-19 test that processes saliva samples and does not require special swabs or collection devices received emergency-use authorization by the U.S. Food and Drug Administration on Saturday. SalivaDirect test is expected to be priced at $10 per sample. Cheap, fast saliva-based test could boost testing frequency. Research for the…
SUMMARY: NPR reports more than 8 in 10 supported aggressive new measures by the federal government, including expanded testing are needed. The author suggests we have relied on poorly coordinated efforts among 50 states and thousands of local jurisdictions to solve a national problem. “The United States is not currently on…
Current tests for active infection of COVID-19 are given long after the infected person has stopped transmitting making results virtually useless for public-health efforts to contain the pandemic. Harvard professor makes the case that our current approach is all wrong. The vast majority of PCR positive tests we currently collect…